ID   CD44_RAT                Reviewed;         503 AA.
AC   P26051; Q99021;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   24-JUL-2024, entry version 170.
DE   RecName: Full=CD44 antigen;
DE   AltName: Full=Extracellular matrix receptor III;
DE            Short=ECMR-III;
DE   AltName: Full=GP90 lymphocyte homing/adhesion receptor;
DE   AltName: Full=HUTCH-I;
DE   AltName: Full=Hermes antigen;
DE   AltName: Full=Hyaluronate receptor;
DE   AltName: Full=Phagocytic glycoprotein 1;
DE            Short=PGP-1;
DE   AltName: Full=Phagocytic glycoprotein I;
DE            Short=PGP-I;
DE   AltName: CD_antigen=CD44;
DE   Flags: Precursor;
GN   Name=Cd44;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=BDIX; TISSUE=Pancreas;
RX   PubMed=1707342; DOI=10.1016/0092-8674(91)90403-l;
RA   Guenthert U., Hofmann M., Rudy W., Reber S., Zoeller M., Haussmann I.,
RA   Matzku S., Wenzel A., Ponta H., Herrlich P.;
RT   "A new variant of glycoprotein CD44 confers metastatic potential to rat
RT   carcinoma cells.";
RL   Cell 65:13-24(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Stevens J.W., Midura R.J.;
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SULFATION AT TYR-288.
RX   PubMed=9692903; DOI=10.1046/j.1432-1327.1998.2550074.x;
RA   Sleeman J.P., Rahmsdorf U., Steffen A., Ponta H., Herrlich P.;
RT   "CD44 variant exon v5 encodes a tyrosine that is sulphated.";
RL   Eur. J. Biochem. 255:74-80(1998).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-447; THR-451 AND SER-467, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cell-surface receptor that plays a role in cell-cell
CC       interactions, cell adhesion and migration, helping them to sense and
CC       respond to changes in the tissue microenvironment. Participates thereby
CC       in a wide variety of cellular functions including the activation,
CC       recirculation and homing of T-lymphocytes, hematopoiesis, inflammation
CC       and response to bacterial infection. Engages, through its ectodomain,
CC       extracellular matrix components such as hyaluronan/HA, collagen, growth
CC       factors, cytokines or proteases and serves as a platform for signal
CC       transduction by assembling, via its cytoplasmic domain, protein
CC       complexes containing receptor kinases and membrane proteases. Such
CC       effectors include PKN2, the RhoGTPases RAC1 and RHOA, Rho-kinases and
CC       phospholipase C that coordinate signaling pathways promoting calcium
CC       mobilization and actin-mediated cytoskeleton reorganization essential
CC       for cell migration and adhesion. {ECO:0000250|UniProtKB:P15379,
CC       ECO:0000250|UniProtKB:P16070}.
CC   -!- SUBUNIT: Interacts with PKN2 (By similarity). Interacts with TIAM1 and
CC       TIAM2 (By similarity). Interacts with HA, as well as other
CC       glycosaminoglycans, collagen, laminin, and fibronectin via its N-
CC       terminal segment. Interacts with UNC119. Interacts with PDPN (via
CC       extracellular domain); this interaction is required for PDPN-mediated
CC       directional migration and regulation of lamellipodia
CC       extension/stabilization during cell spreading and migration (By
CC       similarity). Interacts with RDX, EZR and MSN (By similarity). Interacts
CC       with EGFR (By similarity). Interacts with CD74; this complex is
CC       essential for the MIF-induced signaling cascade that results in B cell
CC       survival (By similarity). {ECO:0000250|UniProtKB:P15379,
CC       ECO:0000250|UniProtKB:P16070}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P15379};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P15379}.
CC       Cell projection, microvillus {ECO:0000250|UniProtKB:P15379}. Secreted
CC       {ECO:0000250|UniProtKB:P16070}. Note=Colocalizes with actin in membrane
CC       protrusions at wounding edges. Co-localizes with RDX, EZR and MSN in
CC       microvilli. {ECO:0000250|UniProtKB:P15379}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=2; Synonyms=Long, Meta-1;
CC         IsoId=P26051-1; Sequence=Displayed;
CC       Name=1; Synonyms=Short;
CC         IsoId=P26051-2; Sequence=VSP_005330;
CC   -!- DOMAIN: The lectin-like LINK domain is responsible for hyaluronan
CC       binding. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P16070}.
CC   -!- PTM: O-glycosylated; contains chondroitin sulfate glycans which can be
CC       more or less sulfated. {ECO:0000250|UniProtKB:P16070}.
CC   -!- PTM: Phosphorylated; activation of PKC results in the dephosphorylation
CC       of Ser-467 (constitutive phosphorylation site), and the phosphorylation
CC       of Ser-433. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M61875; AAA53532.1; -; mRNA.
DR   EMBL; M61874; AAA53534.1; -; mRNA.
DR   EMBL; U52179; AAA97915.1; -; mRNA.
DR   EMBL; U46957; AAA92920.1; -; mRNA.
DR   PIR; B38745; B38745.
DR   RefSeq; XP_006234693.1; XM_006234631.3.
DR   AlphaFoldDB; P26051; -.
DR   SMR; P26051; -.
DR   BioGRID; 247441; 1.
DR   CORUM; P26051; -.
DR   IntAct; P26051; 1.
DR   GlyCosmos; P26051; 8 sites, No reported glycans.
DR   GlyGen; P26051; 9 sites.
DR   iPTMnet; P26051; -.
DR   PhosphoSitePlus; P26051; -.
DR   SwissPalm; P26051; -.
DR   GeneID; 25406; -.
DR   UCSC; RGD:2307; rat. [P26051-1]
DR   AGR; RGD:2307; -.
DR   CTD; 960; -.
DR   RGD; 2307; Cd44.
DR   eggNOG; ENOG502RX7Q; Eukaryota.
DR   InParanoid; P26051; -.
DR   OrthoDB; 5358652at2759; -.
DR   PhylomeDB; P26051; -.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-2160916; Hyaluronan uptake and degradation.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P26051; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0042995; C:cell projection; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0031258; C:lamellipodium membrane; ISS:UniProtKB.
DR   GO; GO:0035692; C:macrophage migration inhibitory factor receptor complex; ISO:RGD.
DR   GO; GO:0005902; C:microvillus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0038024; F:cargo receptor activity; ISO:RGD.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IPI:RGD.
DR   GO; GO:0005540; F:hyaluronic acid binding; ISO:RGD.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0005114; F:type II transforming growth factor beta receptor binding; ISO:RGD.
DR   GO; GO:0001955; P:blood vessel maturation; IEP:RGD.
DR   GO; GO:0060442; P:branching involved in prostate gland morphogenesis; ISO:RGD.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0051216; P:cartilage development; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; IMP:RGD.
DR   GO; GO:0016477; P:cell migration; IMP:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISO:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IEA:GOC.
DR   GO; GO:0030214; P:hyaluronan catabolic process; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0034238; P:macrophage fusion; IMP:RGD.
DR   GO; GO:0070487; P:monocyte aggregation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:2000562; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; ISO:RGD.
DR   GO; GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; ISO:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISO:RGD.
DR   GO; GO:0002906; P:negative regulation of mature B cell apoptotic process; ISO:RGD.
DR   GO; GO:0045590; P:negative regulation of regulatory T cell differentiation; ISO:RGD.
DR   GO; GO:0031175; P:neuron projection development; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:1900625; P:positive regulation of monocyte aggregation; ISO:RGD.
DR   GO; GO:0033031; P:positive regulation of neutrophil apoptotic process; IMP:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0099173; P:postsynapse organization; IDA:SynGO.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0001558; P:regulation of cell growth; IDA:RGD.
DR   GO; GO:2000392; P:regulation of lamellipodium morphogenesis; ISS:UniProtKB.
DR   GO; GO:0099159; P:regulation of modification of postsynaptic structure; IDA:SynGO.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0042110; P:T cell activation; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0002246; P:wound healing involved in inflammatory response; ISO:RGD.
DR   GO; GO:0044319; P:wound healing, spreading of cells; ISS:UniProtKB.
DR   CDD; cd03516; Link_domain_CD44_like; 1.
DR   Gene3D; 3.10.100.10; Mannose-Binding Protein A, subunit A; 1.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR043210; CD44_antigen-like.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR000538; Link_dom.
DR   PANTHER; PTHR10225:SF6; CD44 ANTIGEN; 1.
DR   PANTHER; PTHR10225; HYALURONAN RECEPTOR; 1.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; C-type lectin-like; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Cell projection;
KW   Disulfide bond; Glycoprotein; Membrane; Phosphoprotein; Proteoglycan;
KW   Receptor; Reference proteome; Secreted; Signal; Sulfation; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..21
FT   CHAIN           22..503
FT                   /note="CD44 antigen"
FT                   /id="PRO_0000026691"
FT   TOPO_DOM        22..410
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        411..431
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        432..503
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          35..124
FT                   /note="Link"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT   REGION          172..213
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          228..410
FT                   /note="Stem"
FT   REGION          232..252
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          264..404
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          434..452
FT                   /note="Required for interaction with EZR, MSN and RDX and
FT                   for co-localization to microvilli"
FT                   /evidence="ECO:0000250|UniProtKB:P15379"
FT   COMPBIAS        179..207
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        264..284
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        295..313
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        326..366
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        377..404
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         44
FT                   /ligand="hyaluronan"
FT                   /ligand_id="ChEBI:CHEBI:132153"
FT                   /evidence="ECO:0000250"
FT   BINDING         81
FT                   /ligand="hyaluronan"
FT                   /ligand_id="ChEBI:CHEBI:132153"
FT                   /evidence="ECO:0000250"
FT   BINDING         82
FT                   /ligand="hyaluronan"
FT                   /ligand_id="ChEBI:CHEBI:132153"
FT                   /evidence="ECO:0000250"
FT   BINDING         108
FT                   /ligand="hyaluronan"
FT                   /ligand_id="ChEBI:CHEBI:132153"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         288
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000269|PubMed:9692903"
FT   MOD_RES         433
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P16070"
FT   MOD_RES         447
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         451
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15379"
FT   MOD_RES         467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        28
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        60
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        103
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        114
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        124
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P16070"
FT   CARBOHYD        266
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        274
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        306
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        31..133
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT   DISULFID        56..122
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT   DISULFID        80..100
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT   VAR_SEQ         224..385
FT                   /note="IATTPWVSAHTKQNQERTQWNPIHSNPEVLLQTTTRMTDIDRNSTSAHGENW
FT                   TQEPQPPFNNHEYQDEEETPHATSTTWADPNSTTEEAATQKEKWFENEWQGKNPPTPSE
FT                   DSHVTEGTTASAHNNHPSQRMTTQSQEDVSWTDFFDPISHPMGQGHQTESK -> SDGD
FT                   SSMDPRGGFDTVTHGSELA (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:1707342, ECO:0000303|Ref.2"
FT                   /id="VSP_005330"
FT   CONFLICT        74
FT                   /note="R -> S (in Ref. 2; AAA97915/AAA92920)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   503 AA;  55946 MW;  FB489D009BD4EE22 CRC64;
     MDKVWWHTAW GLLCLLQLSL AQQQIDLNIT CRYAGVFHVE KNGRYSISRT EAADLCEAFN
     TTLPTMAQME LALRKGFETC RYGFIEGHVV IPRIHPNAIC AANNTGVYIL LASNTSHYDT
     YCFNASAPLE EDCTSVTDLP NSFDGPVTIT IVNRDGTRYS KKGEYRTHQE DIDASNIIDE
     DVSSGSTIEK STPEGYILHT DLPTSQPTGD RDDAFFIGST LATIATTPWV SAHTKQNQER
     TQWNPIHSNP EVLLQTTTRM TDIDRNSTSA HGENWTQEPQ PPFNNHEYQD EEETPHATST
     TWADPNSTTE EAATQKEKWF ENEWQGKNPP TPSEDSHVTE GTTASAHNNH PSQRMTTQSQ
     EDVSWTDFFD PISHPMGQGH QTESKGHSSG NQDSGVTTTS GPARRPQIPE WLIILASLLA
     LALILAVCIA VNSRRRCGQK KKLVINSGNG TVEDRKPSEL NGEASKSQEM VHLVNKEPTE
     TPDQFMTADE TRNLQSVDMK IGV
//
